Hallmark pathway | APOE genotype | NES | Adjusted P-value | Leading-edge genes |
---|---|---|---|---|
Allograft rejection | ɛ3/ɛ3 | −1.89 | 0.02 | C2, HLA-DQA1, FAS, HLA-A, UBE2N, HLA-DOB, LTB, F2R, HLA-DRA, TAP2, B2M, CD1D, CD74, MAP3K7 |
ɛ3/ɛ4 | 2.16 | 7.4 × 10−3 | IRF4, CCL22, IRF7, CD74, HLA-DRA, ELF4, IL16, IFNGR2, IL27RA, IL1B | |
Interferon gamma response | ɛ3/ɛ3 | −2.56 | 1.3 × 10−5 | HLA-DQA1, FAS, CFB, BPGM, C1S, HLA-A, LAP3, MVP, PSME2, PSMA2, UBE2L6, SERPING1, DHX58, IFITM2, CD38, B2M, CD74 |
ɛ3/ɛ4 | 1.80 | 0.04 | CD274, CD69, BTG1, ISG20, PML, IRF4, NFKBIA, IRF7, CD74, IL10RA, IRF9 | |
Peroxisome | ɛ3/ɛ3 | −1.81 | 0.03 | IDH2, EHHADH, MVP, ALDH1A1, SCP2, SOD1, ABCD2, MSH2 |
ɛ3/ɛ4 | 1.90 | 0.03 | RDH11, ELOVL5, SLC25A19, CTPS1, SLC23A2, SEMA3C | |
Tnfa signaling via nfkb | ɛ2/ɛ3 | −2.03 | 0.01 | DUSP4, NR4A1, NR4A3, MARCKS, NFAT5, PHLDA1, DUSP2, KYNU, G0S2, ETS2, PTGS2, GCH1, MSC, SOD2, EGR2 |
ɛ3/ɛ4 | 2.27 | 2.5 × 10−3 | TRIP10, CD69, BTG1, DENND5A, PFKFB3, FOS, NFKBIA, LDLR, IER2, JUN, IL1A, PANX1, PNRC1, DUSP1, IFNGR2, OLR1, MAFF, IL1B, TNIP2, CCL20, BIRC2, IER3, GADD45B, KYNU, LITAF, CCRL2, SPHK1, FOSL1 |